Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension

BACKGROUND: There are theoretical concerns that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) could increase the risk of severe Covid-19. OBJECTIVE: To determine if ACEIs and ARBs are associated with an increased risk of Covid-19 hospitalization overall, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Graham, David J., Izurieta, Hector S., Muthuri, Stella G., Zhang, Di, Sandhu, Alexander T., Lu, Yun, Zhao, Yueqin, Feng, Yuhui, Eworuke, Efe, Lyu, Hai, Gandotra, Charu, Smith, Elizabeth R., Avagyan, Armen, Wernecke, Michael, Kelman, Jeffrey A., Forshee, Richard A., MaCurdy, Thomas E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486159/
https://www.ncbi.nlm.nih.gov/pubmed/34599472
http://dx.doi.org/10.1007/s11606-021-07155-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486159/
https://www.ncbi.nlm.nih.gov/pubmed/34599472
http://dx.doi.org/10.1007/s11606-021-07155-z

Ejemplares similares